Table 3.
Comparisons | Posterior Beta of (2(−ddct))ʎ | SE | Adjusted P-valuea | 95% Credible Intervals for Beta | |
---|---|---|---|---|---|
SNHG6 | |||||
Total | Patients vs. healthy subjects | 1.299 | 0.2 | < 0.0001 | [0.89, 1.7] |
Females vs. Males | 0.016 | 0.08 | 0.736 | [-0.14, 0.18] | |
Age (years) | -0.001 | 0.003 | > 0.999 | [-0.01, 0.005] | |
Group a Sex | -0.539 | 0.13 | 0.04 | [-0.78, -0.29] | |
Male | Patients vs. healthy subjects | 0.772 | 0.1 | < 0.0001 | [0.58, 0.98] |
Age | -0.001 | 0.004 | 0.972 | [-0.01, 0.01] | |
Female | Patients vs. healthy subjects | 0.223 | 0.1 | 0.023 | [0.04, 0.43] |
Age | -0.001 | 0.005 | 0.967 | [-0.01, 0.01] | |
CYP27B1 | |||||
Total | Patients vs. healthy subjects | 0.415 | 0.07 | < 0.0001 | [0.28, 0.56] |
Females vs. Males | 0.083 | 0.07 | 0.08 | [-0.05, 0.21] | |
Age (years) | 0.003 | 0.003 | 0.19 | [-0.002, 0.01] | |
Group a Sex | -0.289 | 0.12 | 0.046 | [-0.52, -0.06] | |
Male | Patients vs. healthy subjects | 0.404 | 0.06 | < 0.0001 | [0.28, 0.53] |
Age | 0.002 | 0.003 | 0.717 | [-0.01, 0.01] | |
Female | Patients vs. healthy subjects | 0.189 | 0.1 | 0.419 | [-0.05, 0.36] |
Age | 0.0001 | 0.006 | 0.178 | [-0.01, 0.02] | |
MALAT1 | |||||
Total | Patients vs. healthy subjects | 0.694 | 0.1 | < 0.0001 | [0.5, 0.88] |
Females vs. Males | -0.019 | 0.08 | 0.624 | [-0.18, 0.14] | |
Age (years) | -0.003 | 0.003 | 0.294 | [-0.01, 0.004] | |
Group a Sex | -0.501 | 0.14 | 0.021 | [-0.77, -0.23] | |
Male | Patients vs. healthy subjects | 0.712 | 0.1 | < 0.0001 | [0.52, 0.9] |
Age | -0.002 | 0.004 | 0.439 | [-0.01, 0.01] | |
Female | Patients vs. healthy subjects | 0.186 | 0.13 | 0.096 | [-0.07, 0.44] |
Age | -0.003 | 0.007 | 0.541 | [-0.02, 0.01] | |
Linc00346 | |||||
Total | Patients vs. healthy subjects | 0.4 | 0.09 | 0.012 | [0.21, 0.56] |
Females vs. Males | -0.041 | 0.07 | 0.078 | [-0.17, 0.1] | |
Age (years) | 0.003 | 0.001 | 0.588 | [-0.003, 0.01] | |
Group a Sex | -0.251 | 0.12 | 0.012 | [-0.48, -0.02] | |
Male | Patients vs. healthy subjects | 0.41 | 0.08 | 0.038 | [0.23, 0.56] |
Age | 0.007 | 0.001 | 0.238 | [-0.003, 0.02] | |
Female | Patients vs. healthy subjects | 0.147 | 0.08 | 0.17 | [-0.01, 0.3] |
Age | 0.002 | 0.001 | 0.695 | [-0.01, 0.01] | |
VDR | |||||
Total | Patients vs. healthy subjects | 0.683 | 0.21 | 0.001 | [0.29, 1.1] |
Females vs. Males | -0.088 | 0.12 | 0.292 | [-0.33, 0.17] | |
Age (years) | -0.006 | 0.01 | 0.596 | [-0.02, 0.01] | |
Group a Sex | -0.45 | 0.24 | 0.16 | [-0.93, 0.004] | |
Linc00511 | |||||
Total | Patients vs. healthy subjects | 0.019 | 0.08 | 0.920 | [-0.13, 0.18] |
Females vs. Males | 0.015 | 0.1 | 0.175 | [-0.18, 0.22] | |
Age (years) | 0.007 | 0.001 | 0.006 | [0.001, 0.01] | |
Group a Sex | 0.088 | 0.13 | 0.658 | [-0.17, 0.34] |
aEstimated from frequentist methods, ʎ: Power transformation value estimated from Box-cox or Yeo-Johnson methods